Literature DB >> 24738624

Establishment of reproducible, critical-sized, femoral segmental bone defects in rats.

Kenji Sato1, Yoshinobu Watanabe, Noriko Harada, Satoshi Abe, Takashi Matsushita, Katsuyuki Yamanaka, Tadashi Kaneko, Yuhiro Sakai.   

Abstract

Development of new treatment methodologies for bone nonunion requires validated experimental models for their application into tissue engineering approaches. Critical-sized bone defect (CSBD) models identify the smallest size at which tissue defects fail to completely heal during the experimental period. The purpose of this study was to systematically determine a CSBD in rat femurs using external fixation. Thirty Fischer 344 rats were equally divided into six groups. Bone defects of 1, 2, 3, 4, 5, and 6 mm were created in the diaphysis of the femur, before external fixation. Defects were evaluated radiographically at weekly intervals and histologically at the predefined healing period of 8 weeks. Defects of 4 mm or more failed to achieve union in our model. Nonunions were characterized by the absence of a bridging callus and filling of the defect with fibrous and muscle tissue. Radiographically, bone ends in nonunions were rounded up to 4 weeks postsurgery. Our systematic approach for identification of a CSBD in rat femurs, revealed that externally fixed defects of 4 mm and larger, failed to heal within the 8-week time frame.

Entities:  

Mesh:

Year:  2014        PMID: 24738624     DOI: 10.1089/ten.TEC.2013.0612

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  6 in total

1.  Allogenic Bone Graft Enriched by Periosteal Stem Cell and Growth Factors for Osteogenesis in Critical Size Bone Defect in Rabbit Model: Histopathological and Radiological Evaluation.

Authors:  Hadi Hassibi; Alireza Farsinejad; Shahriar Dabiri; Darioush Voosough; Abbas Mortezaeizadeh; Reza Kheirandish; Omid Azari
Journal:  Iran J Pathol       Date:  2020-04-21

2.  A facile one-stage treatment of critical bone defects using a calcium sulfate/hydroxyapatite biomaterial providing spatiotemporal delivery of bone morphogenic protein-2 and zoledronic acid.

Authors:  Deepak Bushan Raina; Lucas-Maximilian Matuszewski; Corina Vater; Julia Bolte; Hanna Isaksson; Lars Lidgren; Magnus Tägil; Stefan Zwingenberger
Journal:  Sci Adv       Date:  2020-11-27       Impact factor: 14.136

Review 3.  Novel Techniques and Future Perspective for Investigating Critical-Size Bone Defects.

Authors:  Elijah Ejun Huang; Ning Zhang; Huaishuang Shen; Xueping Li; Masahiro Maruyama; Takeshi Utsunomiya; Qi Gao; Roberto A Guzman; Stuart B Goodman
Journal:  Bioengineering (Basel)       Date:  2022-04-11

Review 4.  Surgical Classification for Preclinical Rat Femoral Bone Defect Model: Standardization Based on Systematic Review, Anatomical Analysis and Virtual Surgery.

Authors:  Yu Sun; Heike Helmholz; Regine Willumeit-Römer
Journal:  Bioengineering (Basel)       Date:  2022-09-15

5.  Surface delivery of tunable doses of BMP-2 from an adaptable polymeric scaffold induces volumetric bone regeneration.

Authors:  Michael Bouyer; Raphael Guillot; Jonathan Lavaud; Cedric Plettinx; Cécile Olivier; Véronique Curry; Jean Boutonnat; Jean-Luc Coll; Françoise Peyrin; Véronique Josserand; Georges Bettega; Catherine Picart
Journal:  Biomaterials       Date:  2016-06-29       Impact factor: 12.479

6.  Five Days Granulocyte Colony-Stimulating Factor Treatment Increases Bone Formation and Reduces Gap Size of a Rat Segmental Bone Defect: A Pilot Study.

Authors:  Marietta Herrmann; Stephan Zeiter; Ursula Eberli; Maria Hildebrand; Karin Camenisch; Ursula Menzel; Mauro Alini; Sophie Verrier; Vincent A Stadelmann
Journal:  Front Bioeng Biotechnol       Date:  2018-02-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.